Milestone Pharmaceuticals INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Milestone Pharmaceuticals announces its 2026 Annual Meeting of Shareholders to be held virtually on June 10, 2026.
NASDAQ
Milestone Pharmaceuticals will hold its 2025 Annual Meeting of Shareholders virtually on June 10, 2025, with several key proposals up for vote.
NASDAQ
Milestone Pharmaceuticals will hold its 2025 Annual Meeting of Shareholders virtually on June 10, 2025, to vote on director elections, auditor ratification, an equity incentive plan amendment, and executive compensation.
NASDAQ
Milestone Pharmaceuticals will hold its 2024 Annual Meeting of Shareholders virtually on August 28, 2024, to vote on the election of directors and the appointment of auditors.
NASDAQ
Milestone Pharmaceuticals has appointed two new independent directors, Stuart M. Duty and Andrew R. Saik, to its Board of Directors and entered into a cooperation agreement with Alta Fundamental Advisers LLC.
NASDAQ
Milestone Pharmaceuticals will hold its 2024 Annual Meeting of Shareholders virtually on August 28, 2024, to vote on director elections and auditor appointment.